Clinical Trial Search Results
A Lifetime Partnership with Patients Who Have or May be at Risk of Having Cancer
This study is currently enrolling.
We are asking to study your blood, bone marrow samples, tissues and other body fluids and any parts that make up these tissues, along with your clinical records and survey information. We are building a large database of inform ...
A Phase 1 Dose Escalation With Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMV564 Alone and in Combination with Pembrolizumab in Subjects with Advanced Solid Tumors
This study is currently enrolling.
The purpose of this clinical research study is to learn more about the safety of AMV564, and to learn how AMV564 affects your cancer-specific cells and other blood cells. In addition, the study will look at how long AMV564 can ...
A Phase 2 Trial of MRTX849 in Combination with Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation
This study is currently enrolling.
The main purpose of this study is to evaluate the clinical activity of MRTX849 administered in combination with pembrolizumab in the first-line treatment setting to subjects with Advanced Non-Small Cell Lung Cancer (NSCLC) with ...
A Phase II/III Study of Peri-operative Nivolumab and Ipilimumab in Patients with Locoregional Esophageal and Gastroesophageal Junction Adenocarcinoma
This study is currently enrolling.
This study is being done to answer the following questions: (1) What are the good and bad effects of using usual chemotherapy and radiation plus the immunotherapy, nivolumab, before standard surgery for your condition?; (2) Wha ...
An Open-label, Randomized Phase 3 Study to Evaluate Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with MK-6482 and Lenvatinib (MK-7902), or MK-1308A in Combination with Lenvatinib, versus Pembrolizumab and Lenvatinib, as First-line Treatment in Participants with Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
This study is currently enrolling.
This trial is testing 3 combination therapies in people with a specific type of kidney cancer called advanced clear cell renal cell carcinoma (ccRCC). These 3 therapies are: (1) HIF triplet: pembrolizumab plus MK-6482 (belzutif ...
Antiplatelet Removal and HemocompatIbility Events with the HeartMate 3 Pump
This study is currently enrolling.
The purpose of this research study is to understand if aspirin is needed in patients implanted with the HeartMate 3. Patients with devices like the HeartMate 3 take two blood thinner medicines, specifically warfarin and aspirin ...
CentriMag Failure-to-Wean Post Approval Study
This study is currently enrolling.
You are being invited by your doctor to take part in this research study evaluating the post-market performance of the FDA-approved CentriMag Circulatory Support System because your doctor has determined that this device could ...
Effect of Farxiga on Renal Function and Size in Type 2 Diabetic Patients with Hyperfiltration
This study is currently enrolling.
The purpose of the search is to help researchers learn how the kidney function in newly diagnosed patients with type 2 diabetes respond to dapagliflozin (Farxiga), compared to metformin or glipizide (standard treatments for typ ...
PHASEBIO - A Randomized, Double-Blind, Parallel Group, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of Once Weekly Subcutaneous Injections of a Sustained-Release VIP Analogue, PB1046, in Adult Subjects with Symptomatic Pulmonary Arterial Hypertension
This study is currently enrolling.
You are being asked to participate in this study because your doctors have determined that you have PAH. PAH greatly increases the workload on the right side of the heart and over time may lead to dizziness, difficulty breathi ...